ADVANCES IN ADJUVANT SISTEMIC THERAPY FOR EARLY BREAST CANCER

‘ESCALATION’ OR ‘DE-ESCALATION’

Abstract

This article focuses on ‘escalation’ or ‘de-escalation’ in early breast cancer scenario. In other words, identifying areas where optimal care may be achieved with ‘less’ or ‘more’ treatment. The needs of a specific patient may be better defined through consideration of subset analyses or other individualized approaches to care. Adjuvant therapies for the patient nowadays imply that the treatments need to be adjusted to the patient’s tumor characteristics, co-morbidities, economic constraints and acceptance of available therapies.